Related Experiment Video
Updated: Feb 25, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
DIAGNOSTIC DILEMMAS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Rajat Kumar1, S Dutta2, Harsh Kumar3
1Reader in Medicine & Clinical Hematologist, AFMC, Pune.
Paroxysmal nocturnal hemoglobinuria (PNH) often presents with atypical symptoms, leading to diagnostic delays. Early recognition and specific tests like HAM
Area of Science:
- Hematology
- Internal Medicine
- Clinical Diagnostics
Background:
- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired clonal hematopoietic stem cell disorder.
- PNH is characterized by complement-mediated intravascular hemolysis, thrombosis, and bone marrow failure.
- Delayed diagnosis of PNH can lead to significant morbidity and mortality.
Purpose of the Study:
- To present clinical and hematological parameters in six PNH cases.
- To highlight the diagnostic challenges and delays in PNH.
- To emphasize the importance of specific diagnostic tests for PNH.
Main Methods:
- Retrospective case series analysis.
- Review of clinical presentations and laboratory findings in six PNH patients.
- Analysis of diagnostic pathways and time to diagnosis.
Main Results:
- Mean diagnostic delay was 3.7 years.
- Common presenting symptoms included pallor, reddish urine, and abdominal pain.
- Laboratory findings revealed anemia, unconjugated hyperbilirubinemia, and bone marrow erythroid hyperplasia.
- Complications included gallstones, disseminated tuberculosis, and cardiac failure.
Conclusions:
- PNH can present with atypical features, mimicking other hematological conditions.
- Prompt recognition of suggestive symptoms is crucial for timely diagnosis.
- Specific diagnostic tests, including hemosiderinuria, sucrose lysis test, and HAM's test, are essential for confirming PNH.
More Related Videos
11:54Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues
Published on: October 20, 2019
04:44Author Spotlight: Enhancing Vascular Function and Physical Capacity in Cardiovascular Disease Through Novel Interventions and NIRS Technology
Published on: March 22, 2024
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hemodialysis II: Procedure and Complications